Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is the Thyroglobulin Measurement Under Thyroxine of Prognostic Value Before rhTSH-Aided Radioiodine Ablation in Differentiated Thyroid Carcinoma?

NCT00439127 is registered in ClinicalTrials.gov with Oncology Institute of Southern Switzerland as lead sponsor.

NCT NCT00439127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00439127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is the Thyroglobulin Measurement Under Thyroxine of Prognostic Value Before rhTSH-Aided Radioiodine Ablation in Differentiated Thyroid Carcinoma?
Lead sponsor
Oncology Institute of Southern Switzerland
Phase
Observational
Overall status
Completed
Start date
January 31, 2005
Completion date
January 31, 2007
Enrollment
28
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid carcinoma